Are triple-negative tumours and basal-like breast cancer synonymous?
about
Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer.Association of invasion-promoting tenascin-C additional domains with breast cancers in young women.CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancerSynergistic chemosensitivity of triple-negative breast cancer cell lines to poly(ADP-Ribose) polymerase inhibition, gemcitabine, and cisplatinTriple-negative breast cancer.Treatment options for patients with triple-negative breast cancerMolecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomasHigh IGF-IR activity in triple-negative breast cancer cell lines and tumorgrafts correlates with sensitivity to anti-IGF-IR therapyαB-Crystallin is a Novel Oncoprotein Associated with Poor Prognosis in Breast Cancer.Prediction of Response to Neoadjuvant Chemotherapy: New Biomarker Approaches and Concepts.Triple-Negative Breast Cancer: Clinical and Histological Correlations.Genetic characterization of breast cancer and implications for clinical managementTriple negative breast cancer: an Indian perspective.Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay.Breast cancer subtypes: response to radiotherapy and potential radiosensitisation.Does vimentin help to delineate the so-called 'basal type breast cancer'?Clinicopathological Study of Triple Negative Breast Cancers.Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?Recent advances in systemic therapy. When HER2 is not the target: advances in the treatment of HER2-negative metastatic breast cancer.Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapyAt last: classification of human mammary cells elucidates breast cancer origins.DNA amplifications in breast cancer: genotypic-phenotypic correlations.Beyond triple-negative breast cancer: the need to define new subtypes.Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists.Basal-like breast cancer defined by FOXC1 expression offers superior prognostic value: a retrospective immunohistochemical study.Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences.Clinico-Pathological Characteristics of Triple Negative and Non Triple Negative High Grade Breast Carcinomas with and Without Basal Marker (CK5/6 and EGFR) Expression at a Rural Tertiary Hospital in India.Do 'basal-like' breast cancers really exist?Role of Taxanes in Triple-Negative Breast Cancer: A Study From Tertiary Cancer Center in South India.Predicting and Overcoming Chemotherapeutic Resistance in Breast Cancer.Classical CMF regimen as adjuvant chemotherapy for triple-negative breast cancer may be more effective compared with anthracycline or taxane-based regimens.Radiogenomics analysis identifies correlations of digital mammography with clinical molecular signatures in breast cancer.
P2860
Q30245184-902DCFB7-C16B-40CC-AF56-F50383D3805CQ33552870-7226D2EF-01FA-4F14-A469-8424217F3BF6Q34173505-78118A10-2E87-4F5A-ABC2-AFEED651ECE1Q34176395-23FC8628-3B28-4CFA-9FC9-95F2B3FAE77FQ34204273-0396813E-A494-4210-A813-C0ACDA020433Q34274939-B365DC0D-849E-4062-9617-BC7B23EFB885Q34331406-3E8FF030-782B-4F60-AD8D-6E3AE9550AB5Q34438476-E06F6B1F-3E5C-4F17-ACB4-1A05F83D6E72Q34774874-E2BA13FE-4EFF-4D56-899F-8DCECB7C1CA9Q35142120-C1CEB5B2-224E-41B4-8AE5-103C358E3F3CQ35576250-7267C4BA-0807-4C4E-B788-AACF8151BB88Q35576252-F3F2F33E-BCEA-4496-B04B-5F6BEDAE4B60Q35832016-4150A7FD-809C-4D23-8D0F-B117B21B8147Q35974277-ADDE0B5F-A0EA-4D7C-B767-D3C59EAF0527Q36009626-613D8AE8-BCAE-475C-81E7-1FB31F5A4A75Q36715983-FD94C146-8068-4986-AE11-1041C106ACEEQ37334872-A7052B2C-0A0C-4FB3-893E-9BB432052B61Q37352958-A6D11159-6E50-4606-84FB-527547B878BDQ37356684-A9B9AEC1-4FD0-4287-B880-9DD6A353BD25Q37360151-7231A368-D0D3-4E31-9567-DA04EBA35736Q37467199-4AE0465D-0759-46BB-B8E7-E6059B3399BAQ37524330-D8195DCA-5DD5-41CC-8133-6EDC649B0A8FQ37763102-C16EAE97-4FAA-40EB-B114-0DE195405904Q37782088-4A1F8A31-C333-4331-91F9-BF40DE0310E8Q37809456-398BBF4A-D98F-431E-A8DC-3711594C3B7FQ38411253-70A7DD5F-0949-4AC3-AEF1-AD60B3238A54Q38756385-E7194A88-62DA-4D42-902E-C6F6FB04CBE1Q40882369-EC7D1F3B-D4CA-4952-909C-6F8E283D10A2Q42447530-152D8441-C9BA-43C0-B72A-4087C2C6EE32Q45967836-CAE6E6BE-15EB-4D71-B09F-8EAA834B3C6CQ49544395-E16AF12F-9349-4854-88F3-21323EF3004EQ51036885-7EF68C28-4BC6-4688-AD50-F01BE0C67913Q52622002-3A1CE414-B53E-4867-B64A-AD9009242FDA
P2860
Are triple-negative tumours and basal-like breast cancer synonymous?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Are triple-negative tumours and basal-like breast cancer synonymous?
@ast
Are triple-negative tumours and basal-like breast cancer synonymous?
@en
type
label
Are triple-negative tumours and basal-like breast cancer synonymous?
@ast
Are triple-negative tumours and basal-like breast cancer synonymous?
@en
prefLabel
Are triple-negative tumours and basal-like breast cancer synonymous?
@ast
Are triple-negative tumours and basal-like breast cancer synonymous?
@en
P2093
P2860
P50
P356
P1476
Are triple-negative tumours and basal-like breast cancer synonymous?
@en
P2093
Andrew Tutt
David S P Tan
Torsten O Nielsen
P2860
P2888
P304
404; author reply 405
P356
10.1186/BCR1827
P577
2007-01-01T00:00:00Z
P5875
P6179
1041097170